Erin Clancy

Neither atezolizumab plus chemotherapy nor atezolizumab alone improved overall survival when compared to chemotherapy alone in patients with advanced urothelial cancer in the phase 3 IMvigor130 trial.

Adenocarcinoma has become the most common subtype of lung cancer, according to data from 14 world regions.

As health care providers across the United States grapple with ongoing shortages of cancer drugs, experts are sounding the alarm about drugs that are becoming harder to obtain.

The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.

In a survey of more than 1000 people, 64% said they would trust a diagnosis made by AI over a diagnosis made by a doctor.

Pembrolizumab yielded responses in patients with chordoma, desmoplastic small round cell tumors, epithelioid sarcoma, and other rare sarcomas.

Acalabrutinib and rituximab can yield early complete responses in older patients with previously untreated mantle cell lymphoma.